Related Experiment Video
Updated: May 29, 2025

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
The role of long non-coding RNAs in cardiovascular diseases: A comprehensive review
Xuena Xie1,2, Meiwen Huang1,2, Shudong Ma2,3
1School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau SAR, 999078, China.
Insights
Long non-coding RNAs (lncRNAs) are crucial in cardiovascular diseases (CVDs). This review explores lncRNA roles in CVDs, highlighting their potential as diagnostic biomarkers and therapeutic targets.
Area of Science:
- Molecular Biology
- Genomics
- Cardiovascular Medicine
Background:
- Cardiovascular diseases (CVDs) are a major global health burden, with underlying molecular mechanisms incompletely understood.
- Research traditionally focused on protein-coding genes, but recent genomics advances reveal the significance of long non-coding RNAs (lncRNAs).
- Altered lncRNA expression is implicated in tissue damage and organ dysfunction, contributing to various diseases.
Purpose of the Study:
- To comprehensively review the regulatory mechanisms of lncRNAs in cardiovascular health and disease.
- To discuss the role of lncRNAs in the pathogenesis and progression of specific CVDs.
- To explore the potential of lncRNAs as therapeutic targets and diagnostic biomarkers for CVDs.
Main Methods:
- Literature review and synthesis of existing research on lncRNAs and CVDs.
- Analysis of regulatory mechanisms governing lncRNA expression and function.
- Examination of lncRNA involvement in diverse cardiovascular conditions.
Main Results:
- lncRNAs play critical roles in the development and progression of various cardiovascular diseases.
- Specific lncRNAs are dysregulated in conditions like coronary heart disease, atherosclerosis, heart failure, and cardiomyopathies.
- lncRNAs exhibit tissue-specific expression patterns influenced by internal and external factors.
Conclusions:
- lncRNAs are pivotal in cardiovascular pathophysiology and represent promising diagnostic biomarkers.
- Targeting lncRNAs offers a potential therapeutic strategy for managing cardiovascular diseases.
- Further research into lncRNA regulatory networks is essential for advancing cardiovascular medicine.
Abstract:
Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality worldwide, posing significant challenges to healthcare systems. Despite advances in medical interventions, the molecular mechanisms underlying CVDs are not yet fully understood. For decades, protein-coding genes have been the focus of CVD research. However, recent advances in genomics have highlighted the importance of long non-coding RNAs (lncRNAs) in cardiovascular health and disease. Changes in lncRNA expression specific to tissues may result from various internal or external factors, leading to tissue damage, organ dysfunction, and disease. In this review, we provide a comprehensive discussion of the regulatory mechanisms underlying lncRNAs and their roles in the pathogenesis and progression of CVDs, such as coronary heart disease, atherosclerosis, heart failure, arrhythmias, cardiomyopathies, and diabetic cardiomyopathy, to explore their potential as therapeutic targets and diagnostic biomarkers.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Types of RNA
RNA Performs Diverse...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

